Previous close | 2.0050 |
Open | 1.9860 |
Bid | 2.0050 x N/A |
Ask | 2.1500 x N/A |
Day's range | 1.9860 - 2.0550 |
52-week range | 1.4620 - 5.6500 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore the financial dynamics and strategic clinical advancements as ACXP progresses with its Phase III trials.
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript March 18, 2024 Acurx Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Earnings Results and […]